Van Den Neste, E., André, M., Gastinne, T., Stamatoullas, A., Haioun, C., Belhabri, A., Reman, O., Casasnovas, O., Ghesquieres, H., Verhoef, G., Claessen, M.-J., Poirel, H. A., Copin, M.-C., Dubois, R., Vandenberghe, P., Stoian, I.-A., Cottereau, A. S., Bailly, S., Knoops, L. and Morschhauser, F. (2018) “A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma”, Haematologica. Pavia, Italy, 103(5), pp. 840-848. doi: 10.3324/haematol.2017.180554.